Increasing approval of bioequivalent medicines
The Ministry of Health (MoH), through its Institute of Public Health, expect to raise the number of bioequivalent medicines that are part of the national pharmacological arsenal from 525 to 600 by the end of 2014.
The increase is within the medicine law, which establishes that doctors will be required to write prescriptions using not only brand names but also their generic equivalents. The law also stipulates that pharmacies will be obliged to make available to the public a list of bioequivalent medicines that have been approved by the MoH, so customers can request a change of a prescribed medicine to a bioequivalent option.
Bioequivalence studies are aimed at demonstrating that two drugs containing the same active ingredient in the same dosage, are equivalent in terms of quality, efficiency and safety for the patient.